SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.

NCT01475721 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

11751

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: ADVAIR 100/50mcg
DRUG: ADVAIR 250/50mcg
DRUG: ADVAIR 500/50mcg
DRUG: FLOVENT 100mcg
DRUG: FLOVENT 250mcg
DRUG: FLOVENT 500mcg

Sponsor

GlaxoSmithKline

Collaborators

[object Object]